DFX Intelligence

Data Factory

RIA / WealthRegistered adviserstate registeredstate registeredRAUM none

BISON CAPITAL ADVISORS, LLC

CRD 324668

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:fdf72218-b634-e6fb-f149-5143aa40c62f

Data as of Aug 27, 2026 (this record's last observation) from federal regulator filings. Page built Sep 20, 2026, 11:40 PM UTC and rebuilt at most every 15 minutes.

Relationships: 37
Dated events: 0
On other graphs: 5
Observed: Aug 27, 2026 to Aug 27, 2026
1 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Venture Capitalidentity

Bison Capital Advisors, LLC

Venture manager · cited, shared crd

Independent Sponsorsidentity

Bison Capital Advisors, LLC

Capital provider to sponsors · cited, shared crd

Private Equityidentity

Bison Capital Advisors, LLC

Private equity manager · cited, shared crd

Allocatorsidentity

Bison Capital Advisors, LLC

Manager with allocator commitments · cited, shared crd

Private Creditidentity

BISON CAPITAL ADVISORS, LLC

Private credit manager · cited, shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Firm class: state registeredderivedon the IAPD state feed, not SEC-registered
Private client RAUM: $0derivedItem 5.D individuals plus high net worth individuals
Offices: 0Schedule D 1.F, beyond the principal office
SEC number: 802-127213
CRD: 324668
Filings on the tape: 1
First filed: Aug 27, 2026
Latest filed: Aug 27, 2026
Organised: Limited Liability Company, MO

Private funds

Schedule D 7.B(1); gross asset value as reported, never fund size; reporting ends 2024-12-31; showing 25 of 37

Fund	Type	Reported GAV	As of	Owners	First reported	Status	Form D file
ACM-KYPHA SERIES A PARTNERSHIP	Private Equity Fund	$9.4M	Mar 27, 2024	24	Mar 28, 2023	reported	n/a
ACM-KYPHA SERIES SEED PARTNERSHIP	Private Equity Fund	$6.6M	Mar 27, 2024	34	Mar 28, 2023	reported	n/a
ACM- BONFYRE SERIES A-1	Private Equity Fund	$5.6M	Mar 27, 2024	32	Mar 28, 2023	reported	n/a
ACM-HARBOR MEDTECH SERIES B PREFERRED	Private Equity Fund	$4.5M	Mar 27, 2024	25	Mar 28, 2023	reported	n/a
ACM-SHORT TERM CREDIT FUND PARTNERSHIP	Private Equity Fund	$3.4M	Mar 27, 2024	20	Mar 28, 2023	reported	n/a
ACM-DECK COMMERCE SEED PREFERRED	Private Equity Fund	$3.3M	Mar 28, 2023	14	Mar 28, 2023	reported	n/a
ACM-IDEATE MEDICAL PARTNERSHIP	Private Equity Fund	$3.0M	Mar 27, 2024	4	Mar 28, 2023	reported	n/a
ACM-DECK COMMERCE CONVERTIBLE NOTE	Private Equity Fund	$2.9M	Mar 28, 2023	12	Mar 28, 2023	reported	n/a
ACM-APTIMMUNE SERIES A	Private Equity Fund	$2.7M	Mar 27, 2024	17	Mar 28, 2023	reported	n/a
ACM- APTIMMUNE SERIES B	Private Equity Fund	$2.4M	Mar 27, 2024	13	Mar 28, 2023	reported	n/a
ACM-JURISTAT A5	Private Equity Fund	$2.4M	Mar 27, 2024	12	Mar 28, 2023	reported	n/a
ACM- BONFYRE SERIES A-2	Private Equity Fund	$2.2M	Mar 27, 2024	14	Mar 28, 2023	reported	n/a
ACM-KYPHA SERIES B-1	Private Equity Fund	$2.1M	Mar 27, 2024	14	Mar 28, 2023	reported	n/a
ACM-COMMON PLACE HOLDINGS	Private Equity Fund	$2.0M	Mar 27, 2024	13	Mar 28, 2023	reported	n/a
ACM-KYPHA CONVERTIBLE NOTE	Private Equity Fund	$1.7M	Mar 27, 2024	13	Mar 27, 2024	reported	n/a
ACM-JURISTAT SERIES A-4	Private Equity Fund	$1.5M	Mar 27, 2024	8	Mar 28, 2023	reported	n/a
ACM-IDEATE MEDICAL PART TRANCHE 3	Private Equity Fund	$1.3M	Mar 27, 2024	8	Mar 28, 2023	reported	n/a
ACM-JURISTAT SERIES A-4A	Private Equity Fund	$1.1M	Mar 27, 2024	3	Mar 28, 2023	reported	n/a
ACM-WELLOPP SERIES B PARTNERSHIP	Private Equity Fund	$1.0M	Mar 27, 2024	13	Mar 28, 2023	reported	n/a
ACM- BONFYRE CONVERTIBLE NOTE	Private Equity Fund	$856,750	Mar 27, 2024	5	Mar 28, 2023	reported	n/a
ACM- APTIMMUNE CONVERTIBLE NOTE PARTNERSHIP	Private Equity Fund	$815,000	Mar 27, 2024	9	Mar 28, 2023	reported	n/a
BONFYRE SERIES A	Private Equity Fund	$750,000	Mar 27, 2024	8	Mar 28, 2023	reported	n/a
ACM-IDEATE MEDICAL PART TRANCHE 2	Private Equity Fund	$689,385	Mar 27, 2024	4	Mar 28, 2023	reported	n/a
ACM-JURISTAT CONVERTIBLE NOTE	Private Equity Fund	$667,300	Mar 27, 2024	2	Mar 28, 2023	reported	n/a
ACM-HARBOR MEDTECH SERIES C PREFERRED	Private Equity Fund	$573,750	Mar 27, 2024	13	Mar 28, 2023	reported	n/a

Relationships

Advises (37)

→ ACM-OCT CONVERTIBLE NOTE PARTNERSHIPPrivate fundPrivate Equity Fund, ERA
Mar 27, 2024 to presentfactForm ADV
→ IDEATE MEDICAL PARTNERSHIP TRANCHE 4Private fundPrivate Equity Fund, ERA
Dec 20, 2022 to presentfactForm ADV
→ ACM-COMMON PLACE HOLDINGSPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-INTERSHUNT TECHNOLOGIESPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-INTERSHUNT CONVERTIBLE NOTE AND SERIES BPrivate fundPrivate Equity Fund, ERA
Mar 27, 2024 to presentfactForm ADV
→ ACM-JURISTAT SERIES A-4APrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-JURISTAT A5Private fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-IDEATE MEDICAL PART TRANCHE 2Private fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM- APTIMMUNE CONVERTIBLE NOTE PARTNERSHIPPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM- APTIMMUNE SERIES BPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-KYPHA CONVERTIBLE NOTEPrivate fundPrivate Equity Fund, ERA
Mar 27, 2024 to presentfactForm ADV
→ ACM-HARBOR MEDTECH SERIES C PREFERREDPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-KYPHA SERIES B-1Private fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-SHORT TERM CREDIT FUND PARTNERSHIPPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-JURISTAT SERIES A-4Private fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-WELLOPP SERIES B-1 PARTNERSHIPPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-INTERSHUNT TECHNOLOGIES SERIES A PREFERREDPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-WELLOPP SERIES B PARTNERSHIPPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ BONFYRE SERIES APrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-KYPHA SERIES BPrivate fundPrivate Equity Fund, ERA
Mar 27, 2024 to presentfactForm ADV
→ ACM-IDEATE MEDICAL PARTNERSHIP TRANCHE 5Private fundPrivate Equity Fund, ERA
Mar 27, 2024 to presentfactForm ADV
→ ACM-IDEATE MEDICAL PARTNERSHIPPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-HARBOR MEDTECH SERIES B PREFERREDPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-KYPHA SERIES SEED PARTNERSHIPPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-WELLOPP CONVERTIBLE NOTEPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM- BONFYRE SERIES A-2Private fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-APTIMMUNE SERIES APrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM- BONFYRE CONVERTIBLE NOTEPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM-JURISTAT CONVERTIBLE NOTEPrivate fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
→ ACM- BONFYRE SERIES A-1Private fundPrivate Equity Fund, ERA
Mar 28, 2023 to presentfactForm ADV
and 7 more

Dated events

No dated event names this entity yet.

Provenance

Graph: RIA / Wealth Management
Canonical id: dfx:ria:fdf72218-b634-e6fb-f149-5143aa40c62f
First observed: Aug 27, 2026
Last observed: Aug 27, 2026 24 days ago
Source families: Federal regulator filings
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.